Progesterone
Label Mnemonic: PRGS
Epic Lab Code: LAB529
Downtime Form: A-1a General Laboratory Requisition
Chemistry
6240 RCP
356-3527
Specimen(s):
Plasma
Collection Medium:
Plasma Separator Tube 4.5 mL
Alternate Collection Media:
Call laboratory for additional acceptable specimen collection containers.
Minimum:
3 mL whole blood in light green top tube or TWO Microtainer® devices.
Testing Schedule:
24 hrs/day, 7 days a week, including holidays.
Turn Around Time:
1 hour (upon receipt in laboratory)
Reference Range:
Females: Adult females: Follicular phase: 0.2 - 1.5 ng/mL Ovulation phase: 0.8 - 3.0 ng/mL Luteal phase: 1.7 - 27.0 ng/mL Post-menopausal: < 0.2 - 0.8 ng/mL Pediatric females: < 2 years old: 0.87 - 3.37 ng/mL 2-9 years old: 0.20 - 0.24 ng/mL 10-17 years old: adult levels generally achieved by puberty Males: Adult males: 0.2 - 1.4 ng/mL < 2 years old 0.87 - 3.37 ng/mL 2-9 years old < 0.2 ng/mL 10-17 years old adult levels generally achieved by puberty Reference: Lippe BM, LaFranchi SH, Lavin N, et al: Serum 17-alpha- hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia. J Pediatr 1974;85:782-787.
Test Limitations:
The assay is unaffected by icterus = 54(bilirubin ditaurate is less than 54 mg/dL), hemolysis = 1000 (Hb is less than 1.0 g/dL), lipemia = 200 (Intralipid is less than 720 mg/dL) and biotin is less than 20 ng/mL. (criterion: recovery within plus or minus 10% of initial value). In patients receiving therapy with high biotin doses (i.e. is greater than 5 mg/day) no sample should be taken until at least 8 hours after the last biotin administration. No interference was observed from rheumatoid factors up to a concentration of 2000 IU/mL. In vitro tests were performed on 18 commonly used pharmaceuticals. Of these, only phenylbutazone at therapeutic dosage levels showed interference with the assay (progesterone values depressed). As with all tests containing monoclonal antibodies, erroneous findings may be obtained from samples taken from patients who have been treated with monoclonal mouse antibodies or who have received them for diagnostic purposes. In rare cases, interference due to extremely high titers of antibodies to ruthenium can occur. Progesterone II contains additives which minimize these effects. Extremely high titers of antibodies to streptavidin can occur in isolated cases and cause interference. For diagnostic purposes, the Progesterone II findings should always be assessed in conjunction with the patient's medical history, clinical examination and other findings.
Methodology:
Electrochemiluminescence Immunoassay
CPT Code:
84144